U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197242) titled 'Prognostic Role of Lipoprotein(a) in Elective Percutaneous Coronary Revascularization' on Sept. 20.
Brief Summary: The study investigates the role of Lipoprotein(a) [Lp(a)] levels in predicting cardiovascular risk and adverse events in patients undergoing elective percutaneous coronary intervention (PCI).
Study Start Date: Oct. 01, 2026
Study Type: OBSERVATIONAL
Condition:
PCI
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assiut University
Information provided by (Responsible Party): ahmed gamal abdelhakeem ahmed, Assiut University
Disclaimer: Curated by HT Syndication....